J0900 — Injection, testosterone enanthate and estradiol valerate, up to 1 cc
J0900 is a HCPCS Level II code for injection, testosterone enanthate and estradiol valerate, up to 1 cc. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2014 and is not valid on new claims.
This code has been terminated
CMS terminated J0900 on December 31, 2014. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J0900
- Long descriptor
- Injection, testosterone enanthate and estradiol valerate, up to 1 cc
- Short descriptor
- Testosterone enanthate inj
- Added
- January 1, 1982
- Terminated
- December 31, 2014
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J0900
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0900 is not quite right, the correct code is very often within a few positions of it.
- J0892Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0893Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
- J0894Injection, decitabine, 1 mg
- J0895Injection, deferoxamine mesylate, 500 mg
- J0896Injection, luspatercept-aamt, 0.25 mg
- J0897Injection, denosumab, 1 mg
- J0898Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- J0899Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0901Vadadustat, oral, 1 mg (for esrd on dialysis)
- J0911Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis)
- J0945Injection, brompheniramine maleate, per 10 mg
- J1000Injection, depo-estradiol cypionate, up to 5 mg
- J1010Injection, methylprednisolone acetate, 1 mg
- J1020Injection, methylprednisolone acetate, 20 mgterminated
- J1030Injection, methylprednisolone acetate, 40 mgterminated
- J1040Injection, methylprednisolone acetate, 80 mgterminated
Questions about J0900
What is HCPCS code J0900?
J0900 is a HCPCS Level II code for injection, testosterone enanthate and estradiol valerate, up to 1 cc. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0900?
The CMS HCPCS file marks J0900 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J0900 still valid?
No. J0900 was terminated on December 31, 2014 and should not be used on new claims.